COM:ACURXPHARMA
Acurx Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biopharmaceuticalwebsite
www.acurxpharma.com/linkedin
acurx-pharmaceuticals-incfounding date
Jan 01, 2017ipo date
Jun 25, 2021
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C,...Show More